FDA Approved: MYHIBBIN — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved MYHIBBIN, a mycophenolate mofetil product from Azurity Pharmaceuticals, under an original application (NDA216482). This approval marks the product'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation
• Kidney Transplantation
• Liver Transplantation
• Solid Organ Transplant Rejection Prophylaxis

Drugs mentioned

• MYHIBBIN (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYHIBBIN (MYCOPHENOLATE MOFETIL)